VIDEO Hindi: Jab Market Girta Hai Pharma Badhta Hai
The Contrarian Investor’s Playbook: Why Geopolitical Panics Create the Best Buying Opportunities for Indian Value Investors
March 25, 2026
The PEG Ratio Explained: Peter Lynch’s Secret Weapon for Finding Undervalued Growth Stocks in India
March 26, 2026
March 25, 2026
(Wednesday)
Jab Market Girta Hai, Pharma Badhta Hai!
3 Large Cap Pharma Stocks ALL TIME HIGH Par – Sensex 75,000 Hone Ke Bawajood
Poori Analysis Dekhein (Hindi Mein)
Video Ki Mukhya Baatein:
- Lupin Ltd – Market Cap: 1,07,298 Cr | 52-week high se sirf 1.26% door
- Aurobindo Pharma – Market Cap: 75,978 Cr | 52-week high se sirf 1.67% door
- Emcure Pharma – Market Cap: 30,213 Cr | 52-week high se sirf 1.75% door
- Titan Biotech Ltd – Market Cap: Less than 2,000 Cr | 53 guna antar = bahut bada avsar
Diggijon Ka Tareeka
Rakesh Jhunjhunwala ne Lupin lagbhag 20-25 saal pehle kharidi thi aur usse hold rakha, chahe stock kitni bhi baar upar-neeche hua ho. Warren Buffett ne kabhi market time karne ki koshish nahi ki. Unhone quality kharidi aur har paristhiti mein hold rakha.
Mere anubhav mein, quality companies hamesha poore raaste mein thodi mehngi bani rehti hain. Agar aap badi girawat ka intezaar karte rahenge, toh poora move miss kar sakte hain.
Chhota Sochna Band Karo!
Rs 5-10 Kharido-Becho = Sankirn Soch
BADI TASVEER DEKHO
Titan Biotech Ltd = Indian Stock Market Ka Agla Lupin
Manish Goel | multibaggershares.com | 20 Crore Bhartiya Niveshkon Ke Liye Value Investing Education
Disclaimer: This article is for educational purposes only and does not constitute financial advice. The author may hold positions in stocks mentioned. Always conduct your own research and consult a SEBI-registered financial advisor before making investment decisions. Stock market investments are subject to market risks. Past performance does not guarantee future returns.
📢 Join Our Telegram Channel
Get daily value investing lessons, stock analysis — delivered straight to your phone!
✈️ Join @longtermequityy on Telegram
🔔 Free • No spam • Value investing insights daily
